Procept BioRobotics (PRCT) | Stock Overview & Key Data
Procept BioRobotics Performance Comparison
Stock Range
Today's Range
Low: $47.13
High: $49.99
on August 1, 2025
52 Week Range
Low: $47.04
High: $103.81
on April 7, 2025
on November 11, 2024
All-Time High: $103.81 on November 11, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.8B
EPS
-1.69
P/E Ratio (TTM)
-28.55
Forward P/E
-37.56
P/B Ratio
7.10
PEG Ratio
-37.56
Div. Yield
0.64%
ROE
-27.62%
Beta
1.065
Debt to Equity
21.02
Financial Highlights
Profitability
Gross Margin
63.85%
Operating Margin
-39.67%
Profit Margin
-36.20%
Returns and Earnings
Return on Assets (TTM)
-13.36%
Return on Equity (TTM)
-27.62%
EBITDA
$-90.9M
Net Income (TTM)
$-90.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$4.55
Quarterly Revenue Growth (YoY)
55.30%
Quarterly Earnings Growth (YoY)
55.28%
Dividend Information
Last 12-Month Dividend
$0.38
Current Dividend Yield
0.64%
3-Year Average Dividend Yield
0.12%
3-Year Average Annual Dividend
$0.53
3-Year Total Dividends
$1.59
Ex-Dividend Date
March 31, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Procept BioRobotics PRCT | 2.76B Mid-cap | -10.34% | -11.68% | -5.47% | -29.88% | -39.92% | -12.93% | 18.84% | 24.90% |
| Abbott Laboratories ABT | 221.54B Mega-cap | 0.59% | -6.58% | -2.74% | -0.90% | 12.21% | 14.36% | 16.51% | 25.74% |
| Boston Scientific BSX | 155.95B Large-cap | -0.69% | 0.60% | 2.15% | 2.27% | 17.93% | 41.49% | 157.47% | 170.49% |
| Penumbra PEN | 9.48B Mid-cap | 4.25% | -3.06% | -16.73% | -8.30% | 1.26% | 38.46% | 45.66% | 3.76% |
| Masimo MASI | 8.35B Mid-cap | -6.48% | -8.91% | -5.93% | -10.57% | -8.67% | 44.77% | 0.32% | -29.08% |
| Bio-Rad Laboratories BIO | 7.57B Mid-cap | 7.73% | 14.76% | 18.37% | -19.40% | -12.74% | -15.28% | -47.26% | -45.70% |
Ownership & Short Interest
Insider Ownership
4.22%
Institutional Ownership
93.86%
Shares Short
7M
Short Ratio
9.53
Short % of Shares Outstanding
14.63%
Average 10-Day Volume
1M
Average 90-Day Volume
1M
Procept BioRobotics Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Procept BioRobotics would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PRCT's 52-week high and low?
- In the last 52 weeks, Procept BioRobotics reached a high of $103.81 (on November 11, 2024) and a low of $47.04 (on April 7, 2025).
- What is the market cap and P/E ratio for PRCT?
- Curious about Procept BioRobotics's size and valuation? Its market capitalization stands at 2.76B. When it comes to valuation, the P/E ratio (trailing twelve months) is -28.55, and the forward P/E (looking ahead) is -37.56.
- Does PRCT pay dividends? If so, what's the yield?
- Yes, Procept BioRobotics is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.64%, and the company has paid an average of $0.53 per share annually over the past 3 years.
- Who are Procept BioRobotics's main competitors or similar companies to consider before investing?
When looking at Procept BioRobotics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT221.54B Healthcare Medical Devices 14.36% 16.51% Boston Scientific
BSX155.95B Healthcare Medical Devices 41.49% 157.47% Penumbra
PEN9.48B Healthcare Medical Devices 38.46% 45.66% Masimo
MASI8.35B Healthcare Medical Devices 44.77% 0.32% Bio-Rad Laboratories
BIO7.57B Healthcare Medical Devices -15.28% -47.26% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Procept BioRobotics Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Procept BioRobotics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -27.62%, the Debt to Equity ratio from the most recent quarter is 21.02, and its Gross Profit Margin stands at 63.85%.
- What is the recent revenue and earnings growth for PRCT?
- Looking at Procept BioRobotics's growth, its revenue over the trailing twelve months (TTM) was $249M. Compared to the same quarter last year (YoY), quarterly revenue grew by 55.30%, and quarterly earnings saw a YoY growth of 55.28%.
- How much of PRCT stock is held by insiders and institutions?
- Wondering who owns Procept BioRobotics stock? Company insiders (like executives and directors) hold about 4.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 93.86%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.